Thursday, May 23, 2024, 9:40 am
Berlin – The Federal Association of Drug Manufacturers, Germany’s largest pharmaceutical affiliation, urges future members of the European Parliament to work for a powerful, truthful and aggressive European pharmaceutical trade. Managing Director Dorothee Brakmann emphasizes the important thing function of the EU within the provide of medicines and requires Europe to be strengthened as a pharmaceutical hub: “The way forward for the European pharmaceutical trade is at stake. We want insurance policies to make sure protected well being care whereas innovating.”
BAH has drawn up a place paper on the EU elections and it contains ten important calls for:
- Protecting democracy and the rule of regulation for a powerful and united Europe.
- Improvement of the EU pharmaceutical authorized framework to strengthen innovation and competitiveness.
- Combating drug shortages and strengthening provide chains.
- Promoting digital innovation in healthcare by the European Health Data Space (EHDS).
- Reform of current EU legal guidelines to guard the availability of medicines.
- Reducing paperwork and adapting EU industrial coverage to advertise innovation.
- Promoting well being literacy and prevention.
- Sustainability and environmental safety by dialogue with the pharmaceutical trade.
- Improving the EU Medical Device Regulation.
- Effective EU HTA procedures for the harmonization of medical trial procedures.
From June 6 to 9, residents of the 27 EU member states will elect a brand new European Parliament. This election units the tone for the way forward for Europe and the pharmaceutical trade. BAH is subsequently asking everybody to vote within the European elections and take an lively half in shaping the way forward for Europe. Brakmann explains: “A robust European pharmaceutical trade is important for the well being and well-being of European residents and for the financial competitiveness of the EU.”
An in depth 10-point paper on organizational positioning is on our web site web site out there.
The Federal Association of Drug Manufacturers (BAH) is the biggest pharmaceutical trade affiliation in Germany. It represents the pursuits of round 400 member corporations using round 80,000 folks in Germany. Companies organized within the BAH make an essential contribution to making sure the availability of medicines in Germany. They provide about 80 % of over-the-counter medicine and about two-thirds of prescribed drugs bought in pharmacies, in addition to nearly all of medical provides for sufferers. Underneath www.pharmadeutschland.de There is extra details about BAH.
On March 14, 2024, BAH member corporations voted 97 % in favor of the brand new regulation and the reorganization of the group into Pharma Germany. Under the brand new identify, the illustration of political pursuits can be expanded, a regional organizational construction can be launched and a separate workplace can be opened in Brussels to higher signify the German pharmaceutical trade on the European degree.